Skip to main content
BrightStudy

Clinical research directory

Find Clinical Research Opportunities That May Fit

Answer a few questions to explore currently recruiting studies. Some studies may offer compensation for participants' time and travel.

See possible matchesHow it works
  • No cost to search
  • Participation is voluntary
  • Final eligibility is determined by study staff

Compensation, eligibility and study availability vary. Submitting your information does not guarantee qualification, enrollment, medical treatment or payment.

A woman reading on a tablet at a table in a bright room

How it works

Tell us what types of research interest you

A few broad questions — your ZIP code, an age confirmation and a general area of interest. We do not ask for diagnoses or medical records.

Review possible currently recruiting studies

We show listings sourced from ClinicalTrials.gov, with the NCT number, sponsor, locations and a link to the original record so you can read it yourself.

A study team determines final eligibility

If you ask to be connected, the research site reviews your situation and decides. BrightStudy never makes eligibility or enrollment decisions.

Participation is always optional

You can stop at any point, unsubscribe from emails immediately, or ask us to delete your information.

Current opportunities

Public directory listings sourced from ClinicalTrials.gov. Only studies with a recruiting status are shown, and listings that stop recruiting are removed on the next refresh.

Browse all listings
Recruiting
Public directory listing
NCT07227532

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Listed focus: Atrial Fibrillation

The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).

Basic eligibility summary
Ages 22 Years
Locations
Phoenix, Arizona · Tucson, Arizona · Fountain Valley, California · +20 more
Eligibility summary from the record

* Symptomatic paroxysmal Atrial Fibrillation (AF) who, in the opinion of the investigator, are candidates for catheter ablation for AF * Refractory (that is, ineffective, not tolerated, or not desired) or contraindicated to at least one Class I/III antiarrhythmic drugs (AAD) * Willing and capable of providing consent…

Summarized from the sponsor's posted criteria. The research site makes the final eligibility decision.

Sponsor / responsible party: Biosense Webster, Inc.

Source: ClinicalTrials.gov · Record updated July 30, 2026 · Last checked by BrightStudy August 1, 2026

Compensation is not stated for this listing. BrightStudy does not add compensation information unless it is independently verified with the study partner.

View the full record on ClinicalTrials.gov
Recruiting
Public directory listing
NCT06690398

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Listed focus: Irritability Associated With Autism Spectrum Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) and confirmed by the Kiddie…

Basic eligibility summary
Ages 5 Years to 17 Years
Locations
Dothan, Alabama · Phoenix, Arizona · Anaheim, California · +32 more
Eligibility summary from the record

1. All patients must have a legally authorized representative LAR (eg, parent or legal guardian) who is willing and able to be responsible for the safety and well-being of the patient, provide information about the patient's condition, and accompany the patient to study visits. 2. Able to provide consent as follows:…

Summarized from the sponsor's posted criteria. The research site makes the final eligibility decision.

Sponsor / responsible party: Intra-Cellular Therapies, Inc.

Source: ClinicalTrials.gov · Record updated July 30, 2026 · Last checked by BrightStudy August 1, 2026

Compensation is not stated for this listing. BrightStudy does not add compensation information unless it is independently verified with the study partner.

View the full record on ClinicalTrials.gov
Recruiting
Public directory listing
NCT07062471

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

Listed focus: Carotid Artery Calcification, Carotid Artery Diseases

Prospective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE Study)

Basic eligibility summary
Ages 18 Years
Locations
Little Rock, Arkansas · Rancho Mirage, California · Sacramento, California · +22 more
Eligibility summary from the record

1. Age ≥ 18 years. 2. Patient is able and willing to comply with all assessments in the study. 3. Patient has been informed of the nature of the study, agrees to participate and has signed the approved informed consent form. 4. Patient approved for inclusion by a Patient Screening Committee. 5. Patient must have a…

Summarized from the sponsor's posted criteria. The research site makes the final eligibility decision.

Sponsor / responsible party: Shockwave Medical, Inc.

Source: ClinicalTrials.gov · Record updated July 30, 2026 · Last checked by BrightStudy August 1, 2026

Compensation is not stated for this listing. BrightStudy does not add compensation information unless it is independently verified with the study partner.

View the full record on ClinicalTrials.gov

Why BrightStudy

No cost to search

BrightStudy is free for participants. We never ask you to pay to view a listing or to be referred to a study site.

Clear privacy choices

Email consent is separate and never pre-checked. Your answers are never sent to advertising pixels, analytics platforms or session-replay tools.

Participation is voluntary

Expressing interest is not an application. You are free to decline any study at any stage, including after speaking with a research site.

Direct access to sourced study information

Every public listing links to its ClinicalTrials.gov record and shows when we last checked it, so you can verify what you read.

Frequently asked questions

See what research is recruiting near you

It takes about a minute, costs nothing, and does not commit you to anything. A study team always makes the final eligibility decision.

See possible matches

Compensation, eligibility and study availability vary. Submitting your information does not guarantee qualification, enrollment, medical treatment or payment. BrightStudy is operated by Easy Benefits Help LLC, a Wyoming limited liability company.